ARCHIVES

Irinotecan And Carboplatin Improve Response In NSCLC

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

January 30, 2009

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

Randomized Trial Finds Sunscreen Use Cuts Risk Of Developing Melanoma

December 31, 2010

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

October 30, 2009

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987